Combinib 250mg Tablet
Marketer
Cipla Ltd
Salt Composition
Lapatinib (250mg)
Overview Combinib 250mg Tablet
Oncaspar 250mg tablets treat breast cancer by inhibiting or reducing the proliferation of cancerous cells. Administered alone or in conjunction with other therapies, it addresses advanced breast cancer. Take Oncaspar 250mg on an empty stomach, or one hour before or two hours after eating. Dosage and treatment length depend on disease severity and response. Strict adherence to the prescribed regimen minimizes adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Frequent side effects include nausea, headache, back pain, and respiratory distress. Severe diarrhea necessitates increased fluid intake or medical consultation. Regular blood pressure monitoring may be required. Report severe headache, disorientation, visual disturbances, persistent nausea, or vomiting immediately. Liver function tests are typically conducted before, during, and after treatment. Inform your physician of any pre-existing liver or kidney conditions, and disclose all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners during treatment. A patient support program (PSP) is offered in India through Tata 1mg; contact your doctor or call 1800-102-1618 for details.
Uses of Combinib 250mg Tablet
Malignancy of the mammary gland
Major Benefits of Combinib 250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer the Combinib 250mg Tablet on an empty stomach.
Common Side effects of Combinib 250mg Tablet:
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use Combinib 250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 250mg Combinib Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Combinib 250mg Tablet works:
Combating HER2-positive and EGFR-expressing cancers, the 250mg Combinib tablet interrupts the uncontrolled cell growth driven by these receptors. Its mechanism involves blocking the receptor activity, thereby halting the downstream signaling cascades that fuel tumor development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Combinib 250mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Combinib 250mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening cases, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the 250mg Combinib tablet are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Combinib 250mg Tablets.
KidneyCAUTION
Exercise caution when administering Combinib 250mg Tablets to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Combinib 250mg Tablet use in such patients is limited. Dosage alterations are not advised for patients exhibiting mild to moderate kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Combinib 250mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Data regarding its use in individuals with severe hepatic dysfunction is scarce.
What if you forget to take Combinib 250mg Tablet :
Should you forget to take a Combinib 250mg Tablet, seek medical advice.
Facts to Know About Combinib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Quinazoline Amine Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | TKIs (tyrosine kinase inhibitors) |




